S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
NASDAQ:JYNT

Joint - JYNT Stock Forecast, Price & News

$14.83
-0.25 (-1.66%)
(As of 12/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$14.65
$15.33
50-Day Range
$13.93
$17.47
52-Week Range
$12.85
$72.39
Volume
112,368 shs
Average Volume
219,718 shs
Market Capitalization
$215.48 million
P/E Ratio
296.66
Dividend Yield
N/A
Price Target
$33.17

Joint MarketRank™ Forecast

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
123.6% Upside
$33.17 Price Target
Short Interest
Bearish
8.21% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.09mentions of Joint in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$3.11 M Bought Last Quarter
Proj. Earnings Growth
100.00%
From $0.11 to $0.22 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.18 out of 5 stars

Medical Sector

414th out of 1,034 stocks

Patent Owners & Lessors Industry

5th out of 7 stocks

JYNT stock logo

About Joint (NASDAQ:JYNT) Stock

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

Receive JYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter.

JYNT Stock News Headlines

Joint Insider Trades Send a Signal
See More Headlines
Receive JYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter.

JYNT Company Calendar

Last Earnings
11/04/2021
Today
12/09/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/23/2023

Industry, Sector and Symbol

Industry
Patent owners & lessors
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:JYNT
Employees
316
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$33.17
High Stock Price Forecast
$50.00
Low Stock Price Forecast
$12.00
Forecasted Upside/Downside
+123.6%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

Net Income
$6.58 million
Pretax Margin
0.75%

Debt

Sales & Book Value

Annual Sales
$81.19 million
Cash Flow
$0.94 per share
Book Value
$2.05 per share

Miscellaneous

Free Float
14,021,000
Market Cap
$215.48 million
Optionable
Not Optionable
Beta
1.23

Key Executives

  • Peter D. Holt
    President, Chief Executive Officer & Director
  • Jorge Armenteros
    Senior Vice President-Operations
  • Jacob SingletonJacob Singleton
    Chief Financial Officer & Controller
  • Charles Nelles
    Chief Technology Officer
  • Steve Knauf
    Vice President-Chiropractic and Compliance













JYNT Stock - Frequently Asked Questions

Should I buy or sell Joint stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Joint in the last year. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" JYNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in JYNT, but not buy additional shares or sell existing shares.
View JYNT analyst ratings
or view top-rated stocks.

What is Joint's stock price forecast for 2023?

4 brokers have issued 12 month price targets for Joint's stock. Their JYNT share price forecasts range from $12.00 to $50.00. On average, they anticipate the company's share price to reach $33.17 in the next year. This suggests a possible upside of 123.6% from the stock's current price.
View analysts price targets for JYNT
or view top-rated stocks among Wall Street analysts.

How have JYNT shares performed in 2022?

Joint's stock was trading at $65.69 at the beginning of 2022. Since then, JYNT shares have decreased by 77.4% and is now trading at $14.83.
View the best growth stocks for 2022 here
.

When is Joint's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our JYNT earnings forecast
.

How were Joint's earnings last quarter?

The Joint Corp. (NASDAQ:JYNT) released its quarterly earnings data on Thursday, November, 4th. The company reported $0.13 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.09. The company earned $20.99 million during the quarter, compared to analysts' expectations of $19.48 million. Joint had a net margin of 0.88% and a trailing twelve-month return on equity of 2.82%. During the same quarter in the previous year, the company earned $0.11 earnings per share.

What guidance has Joint issued on next quarter's earnings?

Joint issued an update on its FY 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $100.00 million-$102.00 million, compared to the consensus revenue estimate of $100.57 million.

What is Peter D. Holt's approval rating as Joint's CEO?

87 employees have rated Joint Chief Executive Officer Peter D. Holt on Glassdoor.com. Peter D. Holt has an approval rating of 59% among the company's employees. This puts Peter D. Holt in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Joint own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Aurora Cannabis (ACB), Advanced Micro Devices (AMD), Raytheon Technologies (RTX), Salesforce (CRM), Mastercard (MA), Starbucks (SBUX), Twitter (TWTR), Viking Therapeutics (VKTX), AbbVie (ABBV) and Adobe (ADBE).

When did Joint IPO?

(JYNT) raised $20 million in an IPO on Tuesday, November 11th 2014. The company issued 3,000,000 shares at a price of $6.50 per share. Roth Capital Partners and Feltl and Company served as the underwriters for the IPO and Sanders Morris Harris was co-manager.

What is Joint's stock symbol?

Joint trades on the NASDAQ under the ticker symbol "JYNT."

Who are Joint's major shareholders?

Joint's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (15.65%), Vanguard Group Inc. (8.14%), State Street Corp (3.15%), Skylands Capital LLC (3.12%), Federated Hermes Inc. (2.00%) and Two Sigma Investments LP (1.25%). Insiders that own company stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Matthew E Rubel, Matthew E Rubel, Peter D Holt and Ronald V Davella.
View institutional ownership trends
.

How do I buy shares of Joint?

Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Joint's stock price today?

One share of JYNT stock can currently be purchased for approximately $14.83.

How much money does Joint make?

Joint (NASDAQ:JYNT) has a market capitalization of $215.48 million and generates $81.19 million in revenue each year. The company earns $6.58 million in net income (profit) each year or $0.05 on an earnings per share basis.

How many employees does Joint have?

The company employs 316 workers across the globe.

How can I contact Joint?

Joint's mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The official website for the company is www.thejoint.com. The company can be reached via phone at (480) 245-5960, via email at thejoint@lhai.com, or via fax at 480-513-7989.

This page (NASDAQ:JYNT) was last updated on 12/9/2022 by MarketBeat.com Staff